Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Research Peptides 2026: Supplier Comparison

Before selecting a peptide supplier, labs should evaluate synthesis method, purity verification, batch size, and post-synthesis support. The table below compares key differentiators across supplier categories. Small-batch U.S. synthesizer (e.g., Real Peptides)

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Before selecting a peptide supplier, labs should evaluate synthesis method, purity verification, batch size, and post-synthesis support. The table below compares key differentiators across supplier categories.
  • Small-batch U.S. synthesizer (e.g., Real Peptides)
  • Solid-phase peptide synthesis (SPPS) with real-time coupling verification
  • 98–99.5% by HPLC + MS confirmation
  • Mass spectrometry + amino-acid analysis on every batch
  • High. 10–50g batches allow per-reaction QC
  • 7–14 days custom, 2–3 days stock
  • Best for reproducibility-critical studies; higher cost justified by sequence fidelity and traceability
  • Bulk international supplier
  • Liquid-phase or large-scale SPPS
  • 95–98% by HPLC (sequence errors often undetected)
  • HPLC only; MS available on request for added fee
  • Moderate. 500g+ batches mean single failed coupling affects entire lot
  • 21–45 days
  • Cost-effective for high-volume screening; sequence verification essential before use
  • Contract research organization (CRO)
  • Custom SPPS with client-defined modifications
  • 97–99% depending on complexity
  • Full analytical suite (HPLC, MS, AAA) included in contract
  • Variable. Depends on batch size negotiated
  • 30–60 days
  • Ideal for novel sequences or non-standard modifications; expensive but flexible
  • Academic core facility
  • SPPS on shared equipment
  • 90–97% (QC limited by equipment access)
  • HPLC only; MS requires external submission
  • Low. Synthesis runs shared across multiple labs
  • 14–30 days depending on queue
  • Budget-friendly but quality inconsistent; best for preliminary work, not publication-grade data